Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-08

FDA Approved: PREVYMIS — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved PREVYMIS (letermovir) in an original application for the prophylaxis of cytomegalovirus infection in CMV-seropositive adult recipients of allog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREVYMIS (letermovir)

Snippet

ORIG AP for PREVYMIS (LETERMOVIR)